PJWCreative0 Like PostComments Off on ASCO 2025 Abstract: First in human PK analysis of antibody conjugated liposome encapsulating doxorubicin (HF-K1) in advanced cancer patients: Comparison with ADCs.
PJWCreative0 Like PostComments Off on AACR 2025 Poster: Myeloid cell targeted immune modulation in solid tumor and brain tumor patients: an analysis of NCTO5388487 phase 1 study data.
PJWCreative0 Like PostComments Off on ESMO 2024 Poster: A phase 1 study of the Myeloid-derived suppressor cells modulator HF1K16 in refractory and metastatic cancer patients: preliminary efficacy and safety.
PJWCreative0 Like PostComments Off on ASCO Breakthrough 2024 Poster: Exploratory phase I study of HF1K16 for the treatment of patients with refractory/recurrent advanced glioma
HighField Bio0 Like PostComments Off on American Diabetes Association 2024 Poster: Preliminary study of efficacy and duration of an mRNA based GLP-1R agonist in diabetic monkeys
PJWCreative0 Like PostComments Off on Liposomes : Methods and Protocols: Preparation and Characterization of Trastuzumab Fab-Conjugated Liposomes (Immunoliposomes)
PJWCreative0 Like PostComments Off on Frontiers in Immunology : Sustained Drug Release from Liposomes for the Remodeling of Systemic Immune Homeostatis and the Tumor Microenvironment
PJWCreative0 Like PostComments Off on Pharmaceutical Research: Biodistribution and Non-linear Gene Expression of MRNA LNPs Affected by Delivery Route and Particle Size